EU: Don’t limit Indonesian access to medicine
Posted in category:
Statement
Published on:
In this letter, SOMO – together with a group of NGOs – urge the European Commission to drop provisions that protect intellectual property in the economic agreement (CEPA) between Indonesia-EU. They fear that the so called TRIPS-PLUS provisions will have disastrous consequences for access to medicines in Indonesia.
Do you need more information?
-
Bart-Jaap Verbeek
Researcher
Download
Related news
-
-
Big Pharma raked in USD 90 billion in profits with COVID-19 vaccinesPosted in category:News
Esther de HaanPublished on: -
Pharma’s pandemic profits Published on:
Esther de HaanPosted in category:Publication
Esther de Haan
